U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Kwokcheng Enterprise, Inc. dba Fullei Fresh - 579900 - 08/01/2023
  1. Warning Letters

CLOSEOUT LETTER

Kwokcheng Enterprise, Inc. dba Fullei Fresh MARCS-CMS 579900 —

Delivery Method:
VIA Electronic Mail
Reference #:
23-HAFE4-WLCOL-05
Product:
Food & Beverages
Recipient:
Recipient Name
Mr. Kwok-Cheng Wong
Recipient Title
President
Kwokcheng Enterprise, Inc. dba Fullei Fresh

400 NE 67th Street
Miami, FL 33138-3880
United States

manny@fulleifresh.com
fullei@fulleifresh.com
Issuing Office:
Office of Human and Animal Food Operations East Division IV

United States

Dear Mr. Wong:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter 20-HAFE4-WL-01 dated October 22, 2019. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Pearl E. Lopina -S
Pearl Lopina
Director of Compliance Branch OHAFO, Division IV East

Back to Top